Decentralized Study to Evaluate a Dietary Supplement for Episodes of Mild Acute Stress in Healthy People
Part of paid clinical trials in San Francisco, California.
- Sponsor
- PLT Health Solutions
- Study ID
- NCT07511088
- Status
- Recruiting
Conditions
- Situational Anxiety
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Botanical extract for anxiety — DIETARY_SUPPLEMENTCapsule containing botanical extracts is self-administered by mouth, taken as needed once per day.
- Placebo capsule — DIETARY_SUPPLEMENTCapsule containing inert excipients only
Study Details
The purpose of this decentralized, two-arm, double-blinded, crossover clinical study is to test the efficacy of a supplement to reduce symptoms of acute stress or situational anxiety in healthy volunteers. The main questions it aims to answer are: 1. Does a dietary supplement reduce feelings of anxiety after self-identified episodes of stress or anxiety when compared to their experience after taking a placebo? 2. On a scale of 1-5, how much would the volunteer like to take the assigned treatment in the future? 3. Are any adverse events identified after either treatment, supplement, or placebo? The study volunteers will: During weeks 1-2, self-identify episodes of acute stress or situational anxiety and rate feelings of anxiety over the next five hours after taking the study product assigned for Period 1. During week 3, volunteers will not take any study product nor complete any surveys. During weeks 4-5, self-identify an episode of acute stress or situational anxiety and rate feelings of anxiety over the next five hours after taking the study product assigned for Period 2.
Key Dates
- Start date
- Jan 29, 2026
- Status verified
- Mar 2026
- Primary completion
- Jun 15, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Dietary SupplementA 25 mg dose of a standardized extract from the aerial parts of Sceletium tortuosum, delivered by mouth as needed once per day.
- Placebo Comparator: PlaceboA capsule containing only excipients matched in appearance and size to active comparator.
Primary Outcome Measure
Visual Analog Scale Score [ Time Frame: 30 minutes after intervention administration ]
Central Contacts
- Alethios Support620-206-8006
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Alethios (Virtual) | San Francisco | California | 94117 |
Find similar trials in San Francisco, CA
Related Studies
- Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental ProceduresRecruiting · University of Michigan · Ann Arbor, Michigan